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Wound Healing Delayed in JunB Mutant Mice
JunB, an AP-1 transcription factor, 
is an important regulator of cyto-
kine expression and thus is critically 
involved in the cutaneous response 
to injury and stress. Florin and col-
leagues describe the skin phenotype 
in mice that lack JunB expression in 
the whole skin, including dermal 
fibroblasts, epithelial keratinocytes, and leukocytes. Although these mice survived to 
adulthood and showed a normal cutaneous architecture, they had a dramatic response 
to wounding or TPA treatment, with pronounced epidermal hyperproliferation, dis-
turbed differentiation, and prolonged inflammation. Wound healing was also mark-
edly delayed in JunB mutant mice. See page 902
A John Hancock for Squamous Cell Carcinoma
Haider and colleagues measured the expression of more than 12,000 genes in inva-
sive human squamous cell carcinomas (SCCs). Then, seeking to define gene sets 
associated with hyperplasia and invasiveness, they compared gene expression in 
the SCCs with that in psoriasis vulgaris, which is hyperproliferative but benign and 
without invasive potential. The genetic signature for primary cutaneous SCC sug-
gests potential roles for the WNT5A gene, the WNT receptor FZD, and the growth 
factor PTN. Further characterization of mechanisms governing these and other reg-
ulatory and inflammatory pathways involved with SCCs might reveal control points 
that may lead to the development of molecular and/or immune-based therapies. 
See page 869 
Imiquimod May Prevent UV Immunosuppression
Imiquimod, an immune response modi-
fier, induces cytokine production in Toll-like 
receptor 7-bearing antigen-presenting cells, 
including the cytokine IL-12, a critical effec-
tor molecule for contact hypersensitivity 
(CHS). To test whether imiquimod protects the 
skin immune system against the effects of UV 
light, Thatcher and colleagues treated mice 
with topical imiquimod or its vehicle, or left them untreated, prior to UV exposures. 
Because imiquimod was shown to prevent the loss of CHS, they conclude that topi-
cal imiquimod treatment may play a role in preventing UV-induced immunosup-
pression and thus skin cancer development as well as fully developed skin cancers. 
See page 821
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Psoriasis: Genes and 
Age
A major susceptibility gene 
for psoriasis is located on 
chromosome 6 very close 
to the HLA-Cw6 gene. 
Gudjonsson and colleagues 
typed 1,019 patients with 
chronic plaque psoriasis 
for HLA-C and HLA-B. 
Approximately 64% were 
HLA-Cw*0602 positive. A 
striking new finding was a 
diverging pattern of disease 
severity in HLA-Cw*0602-
positive and -negative patients 
depending on the age of onset 
of the disease. See page 740
UV-Induced Gene 
Expression
Corre and colleagues 
classified six female 
patients as phototype II 
or III, interviewed them 
preoperatively regarding 
skin response to sunlight, 
and then, 5 hours before 
plastic surgery, delivered 
UV irradiation at 2 and 
4 J/cm2 on their abdomens. 
The in vivo UV response 
of irradiated skin biopsies 
and irradiated cultured 
skin explants facilitated 
gene expression analysis 
that revealed the precise 
molecular pathways of UV 
response. Using cultured 
skin explants is an approach 
to studying specific skin 
pigmentation disorders, 
inflammation, local immune 
response, and DNA damage 
following UV irradiation, 
as well as pharmacological 
compounds implicated in 
skin molecular processes. See 
page 916
